Crinetics Pharmaceuticals Initiates Phase 1 Study of CRN01941 for the Treatment of Neuroendocrine Tumors
May 21, 2019 07:30 ET
|
Crinetics Pharmaceuticals, Inc.
SAN DIEGO, May 21, 2019 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of...
Crinetics Pharmaceuticals Appoints Gina Ford, RPh, MBA, as Vice President, Corporate Strategy and Commercial Planning
March 18, 2019 07:30 ET
|
Crinetics Pharmaceuticals, Inc.
SAN DIEGO, March 18, 2019 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on the discovery, development and commercialization of...
Crinetics Pharmaceuticals Announces Upcoming Presentations at ENDO2019
March 14, 2019 16:27 ET
|
Crinetics Pharmaceuticals, Inc.
SAN DIEGO, March 14, 2019 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on the discovery, development and commercialization of...
Crinetics Pharmaceuticals to Present at J.P. Morgan Healthcare Conference
January 02, 2019 16:05 ET
|
Crinetics Pharmaceuticals, Inc.
SAN DIEGO, Jan. 02, 2019 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on the discovery, development and commercialization of...
ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Netshoes (Cayman) Limited and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
December 04, 2018 14:26 ET
|
Schall Law
LOS ANGELES, Dec. 04, 2018 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Netshoes...
PROVECTUS ANNOUNCES PRESENTATION OF PHASE 1 TRIAL OF PV-10 FOR TREATMENT OF SYMPTOMATIC NEUROENDOCRINE TUMORS METASTATIC TO LIVER AT ESMO 2018 CONGRESS
October 23, 2018 09:00 ET
|
Provectus Biopharmaceuticals Inc.
- First cohort of 6 patients enrolled and treated; currently recruiting patients into second cohort KNOXVILLE, TN, Oct. 23, 2018 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced that...
Canadian government inadequately addressing one of the biggest threats to our oceans
May 03, 2017 08:00 ET
|
Oceana Canada
TORONTO, ON--(Marketwired - May 03, 2017) - A report released today from Oceana Canada -- Collateral damage: How to reduce bycatch in Canada's commercial fisheries -- reveals how poorly Canada is...